Abatacept use is associated with steroid dose reduction and improvement in fatigue and CD4-dysregulation in CVID patients with interstitial lung disease
Caroline, von Spee-Mayer, Constanze, Echternach, Prerana, Agarwal, Sylvia, Gutenberger, Veronika, Soetedjo, Sigune, Goldacker, Klaus, WarnatzJournal:
The Journal of Allergy and Clinical Immunology: In Practice
DOI:
10.1016/j.jaip.2020.10.028
Date:
October, 2020
File:
PDF, 9.18 MB
2020
File converter
More search results
More benefits 
